A recent study introduces an innovative method for analyzing body composition using advanced 3D imaging and deep learning ...

FREE TO READ] Critics say fragmented ownership, weak culture and a fixation on financial results have harmed innovation ...

Welcome to the Bama Flea Mall & Antique Center in Leeds, Alabama – a wonderland of nostalgia that’ll make you feel like a kid ...

Enough Trump. Gaza. Greenland, Mexico. Panama. Canada. Enough drama and politics. All the erudite, well-padded old farts (and the young ones, too) who come to this pathetic blog need a reminder of how ...

JinkoSolar is a buy with strong operational efficiency and resilience in the solar market, bolstered by strategic ...

Subin Baral, EY global life sciences deals leader, told GEN M&A deals are expected to increase in 2025, driven by biopharmas that are eager to recoup revenues they expect to lose as their aging ...

Nuvectis is also advancing NXP900 for YES1/SRC-expressing solid tumors, with promising early data showing no dose-limiting ...

From Warren Buffett and Bill Gates to newcomer Reed Hastings of Netflix, the most generous people in the country have doled ...

Pure Hydrogen has hit another milestone with the successful handover of Australia’s first hydrogen fuel-cell-powered ...

The last two years have been just about as good as stock investors could have hoped for. Here’s what to expect going forward.

Ultrasensitive detection of circulating tumor DNA can improve clinical outcomes in aggressive B-cell lymphomas by identifying measurable residual disease. Defining remission is challenging due to ...

The waveLINE-010 trial will compare zilovertamab vedotin, in combination with rituximab plus cyclophosphamide, doxorubicin, ...